“Ok, how are we going to design a quick trial to validate Leronlimab for BC Colon and Lung and continue validating for all those other indications",

My question is this: How long will the trial need to be run in order to prove progression free survival for each of the cancer indications? Can MRI results and CTCs from patients be used to show efficacy like the current mTNBC trial?